vs
Side-by-side financial comparison of OLB GROUP, INC. (OLB) and Q32 Bio Inc. (QTTB). Click either name above to swap in a different company.
Q32 Bio Inc. is the larger business by last-quarter revenue ($1.9M vs $1.8M, roughly 1.1× OLB GROUP, INC.). Q32 Bio Inc. runs the higher net margin — 2991.2% vs -83.7%, a 3074.9% gap on every dollar of revenue.
OLB Group, Inc. is a global financial technology provider offering omnichannel payment processing solutions, e-commerce enablement tools, and digital banking services for small and medium-sized enterprises across North America, Europe, and key Asia-Pacific markets. Its core segments include merchant services, crypto payment integration, and cloud-based business management platforms.
Q32 Bio Inc. is a clinical-stage biotechnology company focused on developing targeted antibody-based immunotherapies for autoimmune disorders, inflammatory conditions and rare immunological diseases with unmet medical needs, operating primarily across North America and European markets.
OLB vs QTTB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.8M | $1.9M |
| Net Profit | $-1.5M | $57.7M |
| Gross Margin | — | — |
| Operating Margin | -83.7% | — |
| Net Margin | -83.7% | 2991.2% |
| Revenue YoY | -35.2% | — |
| Net Profit YoY | 67.5% | 506.9% |
| EPS (diluted) | $-0.48 | $4.70 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.8M | $1.9M | ||
| Q3 25 | $2.3M | $-220.0K | ||
| Q2 25 | $2.3M | $-284.0K | ||
| Q1 25 | $2.3M | $-371.0K | ||
| Q4 24 | $2.7M | $0 | ||
| Q3 24 | $3.1M | $0 | ||
| Q2 24 | $3.5M | $0 | ||
| Q1 24 | $3.5M | $0 |
| Q4 25 | $-1.5M | $57.7M | ||
| Q3 25 | $-1.2M | $-7.4M | ||
| Q2 25 | $-2.1M | $-9.5M | ||
| Q1 25 | $-1.1M | $-11.0M | ||
| Q4 24 | $-4.6M | $-14.2M | ||
| Q3 24 | $-1.6M | $-17.6M | ||
| Q2 24 | $-2.6M | $-17.0M | ||
| Q1 24 | $-2.4M | $1.0M |
| Q4 25 | -83.7% | — | ||
| Q3 25 | -49.1% | 3444.1% | ||
| Q2 25 | -74.8% | 3229.2% | ||
| Q1 25 | -36.6% | 3296.0% | ||
| Q4 24 | -166.0% | — | ||
| Q3 24 | -52.9% | — | ||
| Q2 24 | -74.3% | — | ||
| Q1 24 | -82.6% | — |
| Q4 25 | -83.7% | 2991.2% | ||
| Q3 25 | -50.8% | 3358.6% | ||
| Q2 25 | -93.7% | 3341.2% | ||
| Q1 25 | -46.9% | 2973.3% | ||
| Q4 24 | -167.1% | — | ||
| Q3 24 | -52.9% | — | ||
| Q2 24 | -75.2% | — | ||
| Q1 24 | -67.8% | — |
| Q4 25 | $-0.48 | $4.70 | ||
| Q3 25 | $-0.13 | $-0.60 | ||
| Q2 25 | $-0.66 | $-0.78 | ||
| Q1 25 | $-0.47 | $-0.90 | ||
| Q4 24 | $-3.55 | $2.63 | ||
| Q3 24 | $-0.92 | $-1.46 | ||
| Q2 24 | $-1.49 | $-1.42 | ||
| Q1 24 | $-0.14 | $-6.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $48.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.6M | $42.0M |
| Total Assets | $12.3M | $61.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $48.3M | ||
| Q3 25 | — | $49.0M | ||
| Q2 25 | — | $54.8M | ||
| Q1 25 | $29.3K | $65.5M | ||
| Q4 24 | $27.4K | $78.0M | ||
| Q3 24 | $41.3K | $89.1M | ||
| Q2 24 | $53.3K | $97.7M | ||
| Q1 24 | $3.3K | $115.5M |
| Q4 25 | $4.6M | $42.0M | ||
| Q3 25 | $5.3M | $-18.4M | ||
| Q2 25 | $6.4M | $-12.2M | ||
| Q1 25 | $2.3M | $-4.0M | ||
| Q4 24 | $3.2M | $5.7M | ||
| Q3 24 | $6.7M | $18.3M | ||
| Q2 24 | $8.3M | $33.5M | ||
| Q1 24 | $11.0M | $48.8M |
| Q4 25 | $12.3M | $61.8M | ||
| Q3 25 | $12.2M | $57.8M | ||
| Q2 25 | $12.4M | $66.1M | ||
| Q1 25 | $12.5M | $79.1M | ||
| Q4 24 | $12.7M | $92.3M | ||
| Q3 24 | $15.9M | $104.5M | ||
| Q2 24 | $16.6M | $124.2M | ||
| Q1 24 | $18.3M | $152.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.3M | $-6.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | -0.11× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.3M | $-6.2M | ||
| Q3 25 | $-115.5K | $-4.2M | ||
| Q2 25 | $-1.0M | $-10.7M | ||
| Q1 25 | $-155.8K | $-12.5M | ||
| Q4 24 | $-2.6M | $-11.4M | ||
| Q3 24 | $-376.7K | $-19.5M | ||
| Q2 24 | $-785.5K | $-22.2M | ||
| Q1 24 | $-424.7K | $-14.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-11.4M | ||
| Q3 24 | — | $-19.6M | ||
| Q2 24 | — | $-22.2M | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | -0.11× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -14.14× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OLB
| Transaction And Processing Fees | $1.7M | 94% |
| Other | $99.2K | 6% |
QTTB
Segment breakdown not available.
